About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,816 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,816 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2961-2980 of 10,816 trials

RecruitingA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerThis is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and…NCT06532006·Anaheim, California and 207 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.This open-label, Phase I study will evaluate the safety, tolerability, and pharmacokinetics of increasing doses of GDC-0853 in patients with relapsed or refractory B-cell…NCT01991184·Stanford, California and 9 others

CompletedA Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast CancerThis single-arm open-label study assessed the safety, feasibility, and efficacy of trastuzumab emtansine (T-DM1) after the completion of anthracycline-based adjuvant/neoadjuvant…NCT01196052·Fort Myers, Florida and 43 others

CompletedA Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsThe purpose of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus lubiprostone in constipated adults.NCT02481947·Mobile, Alabama and 49 others

CompletedPhase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the PancreasPhase III Metastatic Pancreatic CancerNCT00844649·Birmingham, Alabama and 192 others

Active not recruitingLong-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group StudiesThis clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study.NCT00736749·Birmingham, Alabama and 163 others

Active not recruitingA Study Evaluating APG777 in Atopic DermatitisThis is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD).NCT06395948·Fountain Valley, California and 93 others

CompletedIspinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian CancerThe purpose of this study is to determine how effective and safe a new investigational drug is in treating persistent or recurrent ovarian cancer in patients who have received a…NCT00097409·Birmingham, Alabama and 8 others

TerminatedA Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerThe main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery.NCT04752332·Glendale, Arizona and 114 others

CompletedEfficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's DiseaseThis is a randomized, double-blind, multicenter, phase III study to evaluate the safety and efficacy of 2 dosing regiments of Pasireotide long acting release (LAR) in patients…NCT01374906·Phoenix, Arizona and 81 others

RecruitingRett Syndrome RegistryThe Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome.NCT05432349·Birmingham, Alabama and 18 others

Active not recruitingDECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive BiomarkersDECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm).NCT04165564·Birmingham, Alabama and 18 others

CompletedChemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003298·Denver, Colorado and 29 others

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others

RecruitingETHAN - ET for Male BCThis research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most…NCT05501704·Washington D.C., District of Columbia and 8 others

CompletedSafety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyOpen-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR)NCT00908349·Huntsville, Alabama and 57 others

RecruitingHome-Based Cardiac Rehabilitation for Patients With Heart FailureThe vast majority of individuals with heart failure do not participate in center based cardiac rehabilitation (CBCR).NCT06479876·Nashville, Tennessee

RecruitingClinical Outcomes of the ALPS Proximal Humerus Plating SystemThe purpose of this study is to document the performance and clinical outcomes of the A.L.P.S® Proximal Humerus Plating System.NCT03328650·Nashville, Tennessee

Active not recruitingA Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract CancerTo determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT) and recommended Phase 2 dose (RP2D) in patients who receive FF-10832 (Gemcitabine…NCT03440450·Scottsdale, Arizona and 6 others

TerminatedMilademetan in Advanced/Metastatic Solid TumorsPhase 2, multicenter, single-arm, open-label basket study designed to evaluate the safety and efficacy of milademetan in patients with advanced or metastatic solid tumors…NCT05012397·Palo Alto, California and 13 others

PreviousPage 149 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville